annual FCF:
-$117.11M-$74.04M(-171.94%)Summary
- As of today (September 14, 2025), MLTX annual free cash flow is -$117.11 million, with the most recent change of -$74.04 million (-171.94%) on December 31, 2024.
- During the last 3 years, MLTX annual FCF has fallen by -$81.88 million (-232.45%).
- MLTX annual FCF is now -36877.20% below its all-time high of -$316.70 thousand, reached on December 1, 2020.
Performance
MLTX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$54.53M-$16.36M(-42.84%)Summary
- As of today (September 14, 2025), MLTX quarterly free cash flow is -$54.53 million, with the most recent change of -$16.36 million (-42.84%) on June 30, 2025.
- Over the past year, MLTX quarterly FCF has dropped by -$26.64 million (-95.52%).
- MLTX quarterly FCF is now -50484.42% below its all-time high of -$107.80 thousand, reached on March 1, 2021.
Performance
MLTX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$166.76M-$26.64M(-19.01%)Summary
- As of today (September 14, 2025), MLTX TTM free cash flow is -$166.76 million, with the most recent change of -$26.64 million (-19.01%) on June 30, 2025.
- Over the past year, MLTX TTM FCF has dropped by -$101.83 million (-156.83%).
- MLTX TTM FCF is now -52555.92% below its all-time high of -$316.70 thousand, reached on December 1, 2020.
Performance
MLTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
MLTX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -171.9% | -95.5% | -156.8% |
| 3 y3 years | -232.4% | -162.7% | -275.1% |
| 5 y5 years | -10000.0% | - | - |
MLTX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -232.4% | at low | -504.3% | at low | -296.8% | at low |
| 5 y | 5-year | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
MLTX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$54.53M(+42.8%) | -$166.76M(+19.0%) |
| Mar 2025 | - | -$38.17M(-21.5%) | -$140.12M(+19.7%) |
| Dec 2024 | -$117.11M(+171.9%) | -$48.65M(+91.5%) | -$117.11M(+44.4%) |
| Sep 2024 | - | -$25.41M(-8.9%) | -$81.09M(+24.9%) |
| Jun 2024 | - | -$27.89M(+84.0%) | -$64.93M(+32.0%) |
| Mar 2024 | - | -$15.16M(+20.0%) | -$49.20M(+14.2%) |
| Dec 2023 | -$43.06M | -$12.63M(+36.5%) | -$43.06M(+2.5%) |
| Sep 2023 | - | -$9.25M(-23.9%) | -$42.03M(-0.2%) |
| Jun 2023 | - | -$12.16M(+34.7%) | -$42.13M(-17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$9.02M(-22.2%) | -$50.73M(-9.3%) |
| Dec 2022 | -$55.91M(+58.7%) | -$11.60M(+24.0%) | -$55.91M(+8.0%) |
| Sep 2022 | - | -$9.35M(-55.0%) | -$51.78M(+16.5%) |
| Jun 2022 | - | -$20.76M(+46.2%) | -$44.46M(-9.8%) |
| Mar 2022 | - | -$14.20M(+90.1%) | -$49.32M(+40.0%) |
| Dec 2021 | -$35.23M(>+9900.0%) | -$7.47M(+268.0%) | -$35.23M(+25.5%) |
| Sep 2021 | - | -$2.03M(-92.1%) | -$28.07M(+7.8%) |
| Jun 2021 | - | -$25.62M(>+9900.0%) | -$26.04M(+6034.7%) |
| Mar 2021 | - | -$107.80K(-66.0%) | -$424.50K(+34.0%) |
| Dec 2020 | -$316.70K | -$316.70K | -$316.70K |
FAQ
- What is MoonLake Immunotherapeutics annual free cash flow?
- What is the all time high annual FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual FCF year-on-year change?
- What is MoonLake Immunotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly FCF year-on-year change?
- What is MoonLake Immunotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM FCF year-on-year change?
What is MoonLake Immunotherapeutics annual free cash flow?
The current annual FCF of MLTX is -$117.11M
What is the all time high annual FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual free cash flow is -$316.70K
What is MoonLake Immunotherapeutics annual FCF year-on-year change?
Over the past year, MLTX annual free cash flow has changed by -$74.04M (-171.94%)
What is MoonLake Immunotherapeutics quarterly free cash flow?
The current quarterly FCF of MLTX is -$54.53M
What is the all time high quarterly FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly free cash flow is -$107.80K
What is MoonLake Immunotherapeutics quarterly FCF year-on-year change?
Over the past year, MLTX quarterly free cash flow has changed by -$26.64M (-95.52%)
What is MoonLake Immunotherapeutics TTM free cash flow?
The current TTM FCF of MLTX is -$166.76M
What is the all time high TTM FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM free cash flow is -$316.70K
What is MoonLake Immunotherapeutics TTM FCF year-on-year change?
Over the past year, MLTX TTM free cash flow has changed by -$101.83M (-156.83%)